Improvement of acute phase symptoms of pemphigus foliaceus with spesolimab

• Shohei Iida, MD, PhD,
• Ken Muramatsu, MD, PhD,
• Ayaka Mizuno, MD,
• Akinobu Hayashi, MD, PhD,
• Yuki Mizutani, MD, PhD,
• Hideyuki Ujiie, MD, PhD,
• Kazumitsu Sugiura, MD, PhD,
• Keiichi Yamanaka, MD, PhD

Affiliations

Shohei Iida, MD, PhD

Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan

Ken Muramatsu, MD, PhD

Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

Ayaka Mizuno, MD

Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan; Department of Dermatology, Yokkaichi Municipal Hospital, Yokkaichi, Mie, Japan

Akinobu Hayashi, MD, PhD

Department of Oncologic Pathology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan

Yuki Mizutani, MD, PhD

Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan

Hideyuki Ujiie, MD, PhD

Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan

Kazumitsu Sugiura, MD, PhD

Department of Dermatology, Fujita Health University, Toyoake, Aichi, Japan

Keiichi Yamanaka, MD, PhD

Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Mie, Japan; Correspondence to: Keiichi Yamanaka, MD, PhD, Department of Dermatology, Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Japan.